ARCHIVES

Study: Prostate Cancer Classifier Can Predict Risk Better Than PSA, Gleason Score, Tumor Stage

This article is from The Cancer Letter archive.

Vol. 37 No. 2 | February 28, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Ceases Exclusion Of Women From Early Drug Studies

May 7, 1993

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

July 25, 2014

HHS Agency Says It Has No Jurisdiction And No Cause to Act on I-ELCAP Allegations

March 2, 2012

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

More Than 300 request RFP for New Community Oncology Program

May 25, 1979